The Melanoma Research Foundation was originally founded in 1996 by Diana Ashby, who through the course of her own melanoma cancer treatment became disheartened at the lack of effective medical treatment options. Driven by her empathy for fellow sufferers and determined to change the trajectory of those impacted by the disease, the Melanoma Research Foundation was born. Though Diana tragically died within a year of its founding, the foundation continues to honor her memory by championing research and disseminating education around the prevention, diagnosis, and treatment of the disease.
In 2019, a number of research awards will be offered:
CURE Ocular Melanoma Team Award (CURE OM Team) — Grants of up to $250,000 over two years will awarded in support of research on ocular melanoma. Teams should consist of a principle investigator and at least one co-PI (ideally from different institutions). Teams consisting of both basic scientists and clinicians are encouraged, as is the inclusion of a junior scientist.
Established Investigator Awards (EIA) — Grants of up to $200,000 over two years will be awarded to established or senior melanoma researchers, or those who wish to transition into melanoma research.
Career Development Awards (CDA) — Grants of up to $100,000 over two years will be awarded to junior investigators who are beginning their career in melanoma research.
Medical Student Awards — One-year grants of up to $3,000 will be given to encourage medical students to engage in a short melanoma research-driven clinical or laboratory-based project.
Specific topic proposals should be informed by current unmet needs in melanoma research and include prevention, metastases, response to treatment, and epigenetics.
Eligible candidates must hold a PhD, MD, or equivalent.
See the Melanoma Research Foundation website for a detailed program description and application instructions.